Lab
Genemarkers LLC
Genemarkers LLC was paid $1.07M by Medicaid between Jun 2020 and Feb 2023, across 5 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 80% of everything it billed.
33Billing provider infoGENEMARKERS LLC
KALAMAZOO, MI 49007
KALAMAZOO, MI 49007
33aNPI1770909319assigned 03/06/2014
33bProvider typeClinical Medical Laboratory
28Total paid$1.07M
24GClaims30,349
24DCodes billed5
24AFirst – last monthJun 2020 – Feb 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Michigan
Rank by total paid#43 of 108
Median peer was paid$588K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 8,197 | $374K | |
| 2021 | 15,388 | $431K | |
| 2022 | 6,716 | $263K | |
| 2023 | 48 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 80% | 13,885 | 10,215 | $854K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16% | 9,289 | 7,820 | $166K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.4% | 2,617 | 1,340 | $47K |
| 99001 | <1% | 3,339 | 2,825 | $3K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 1,219 | 647 | $25.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANDO, CHRISTIE (BUSINESS OFFICE MANAGER)